This article analyzes differences in prescription drug pricing transparency practices among 3 Organization for Economic Co-operation and Development member nations: the United Kingdom, Germany, and Canada. Specifically, this article compares these countries’ policies on list and net price disclosures and…
In health care, lack of transparency about the cost of health care services to patients during clinical encounters has contributed to increased costs and high out-of-pocket expenses. Federal policy has responded to the need for more transparency and spurred discussion…
Negative health consequences stemming from the financial burden of care on patients and their loved ones are documented as financial toxicity in the literature, and these consequences should be included in informed consent discussions during patient-clinician interactions. However, codes of…
This activity is comprised of five multiple-choice questions based on the content of an AMA Journal of Ethics podcast about medical child abuse, sites of pediatric neglect, and how clinicians can best carry out their responsibilities as mandatory reporters. The…
This activity is comprised of five multiple-choice questions based on the content of an AMA Journal of Ethics podcast about “observed decompensation” as a post-Dobbs clinical and ethical phenomenon and its influences on health professionalism. The featured guests are Dr…
In this video edition of Ethics Talk, journal editor in chief, Dr Audiey Kao, talks with organizers of MIT Hacking Racism in Healthcare about design thinking as a way to find solutions to combat structural racism and advance health equity.
Compassion has long been a bulwark of mental health law. Civil commitment, guardianship, mandated clinical intervention, diversion courts, involuntary medication, insanity defenses, and aid-in-sentencing evaluations are all elements of compassionate mental health practice. Parens patriae (the state as parent) and…
Humans exploring beyond low-Earth orbit face environmental challenges coupled with isolation, remote operations, and extreme resource limitations in which personalized medicine, enabled by genetic research, might be necessary for mission success. With little opportunity to test personalized countermeasures broadly, the…
CRISPR/Cas9 is a rapidly developing gene editing technology that will soon have many clinical applications. As with many other new technologies, somatic gene editing with CRISPR/Cas9 raises concerns about equitable access to therapies by historically disenfranchised racial and ethnic minorities….
Reproductive health disparities particularly those experienced by racial and ethnic minority groups are considered a persistent public health issue in the United States. Frameworks that focus on social determinants of health seek to identify the forces producing these disparities, particularly…
© 2025
American Board of Medical Specialties | Policies | Sitemap | Terms of Use | www.abms.org
